CN103981147B - 一种新的制备肝实质细胞的方法 - Google Patents
一种新的制备肝实质细胞的方法 Download PDFInfo
- Publication number
- CN103981147B CN103981147B CN201310050796.7A CN201310050796A CN103981147B CN 103981147 B CN103981147 B CN 103981147B CN 201310050796 A CN201310050796 A CN 201310050796A CN 103981147 B CN103981147 B CN 103981147B
- Authority
- CN
- China
- Prior art keywords
- cell
- liver
- cells
- hihep
- parenchymal cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Marine Sciences & Fisheries (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Abstract
Description
Claims (12)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310050796.7A CN103981147B (zh) | 2013-02-08 | 2013-02-08 | 一种新的制备肝实质细胞的方法 |
JP2015556390A JP6426627B2 (ja) | 2013-02-08 | 2014-02-08 | ヒト肝細胞様細胞およびその使用 |
US14/422,307 US9623048B2 (en) | 2013-02-08 | 2014-02-08 | Human hepatocyte-like cells and uses thereof |
PCT/CN2014/071898 WO2014121758A1 (en) | 2013-02-08 | 2014-02-08 | Human hepatocyte-like cells and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310050796.7A CN103981147B (zh) | 2013-02-08 | 2013-02-08 | 一种新的制备肝实质细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103981147A CN103981147A (zh) | 2014-08-13 |
CN103981147B true CN103981147B (zh) | 2017-11-10 |
Family
ID=51273317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310050796.7A Active CN103981147B (zh) | 2013-02-08 | 2013-02-08 | 一种新的制备肝实质细胞的方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9623048B2 (zh) |
JP (1) | JP6426627B2 (zh) |
CN (1) | CN103981147B (zh) |
WO (1) | WO2014121758A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3186376B1 (en) | 2014-08-27 | 2019-03-20 | Caribou Biosciences, Inc. | Methods for increasing cas9-mediated engineering efficiency |
KR101993045B1 (ko) * | 2017-08-25 | 2019-06-26 | 건국대학교 글로컬산학협력단 | 체세포에서 유도담관줄기세포로의 교차분화방법 |
KR101993044B1 (ko) * | 2017-08-25 | 2019-06-26 | 건국대학교 글로컬산학협력단 | 체세포에서 유도간줄기세포로의 교차분화방법 |
CN110272997B (zh) * | 2018-03-14 | 2023-04-28 | 华中科技大学同济医学院附属同济医院 | 一种C/EBPβ基因或者蛋白的用途 |
CN108588006A (zh) * | 2018-05-10 | 2018-09-28 | 华东理工大学 | 一种用于肝细胞三维培养的生物支架及其制备方法和应用 |
CN109022411B (zh) * | 2018-08-09 | 2022-11-29 | 北京理工大学 | 基于电沉积和机器人操作的3d微组织构建方法 |
EP3931304A4 (en) * | 2019-02-26 | 2022-10-19 | Peking University | COMPOSITIONS AND METHODS FOR REPROGRAMMING NON-HEPATOCYTIC CELLS INTO HEPATOCYTIC CELLS |
CN110438157B (zh) | 2019-08-05 | 2020-11-24 | 上海赛立维生物科技有限公司 | 肝前体样细胞系、构建方法以及在生物人工肝领域的应用 |
CN112147336B (zh) * | 2019-09-18 | 2023-04-28 | 首都医科大学附属北京佑安医院 | 一种检测和评估肝再生的标志物及其用途 |
CN111154807B (zh) * | 2020-01-17 | 2023-03-24 | 山东农业大学 | 一种分泌型的崂山奶山羊乳腺上皮细胞系的构建方法 |
MX2022011245A (es) | 2020-03-11 | 2023-01-11 | Bit Bio Ltd | Método de generación de células hepáticas. |
CN111849884B (zh) * | 2020-07-30 | 2021-02-19 | 山东天川精准医疗科技有限公司 | 一种人胎盘羊膜干细胞向肝细胞定向分化的诱导方法 |
CN114712393B (zh) * | 2020-12-18 | 2024-01-19 | 中国人民解放军海军军医大学第三附属医院 | Hnf-1α基因修饰的间充质干细胞在防治肝癌中的用途 |
JPWO2022145420A1 (zh) * | 2020-12-28 | 2022-07-07 | ||
WO2022145419A1 (ja) * | 2020-12-28 | 2022-07-07 | 持田製薬株式会社 | 化学架橋アルギン酸を用いた多層構造体 |
CN116710110A (zh) * | 2020-12-28 | 2023-09-05 | 持田制药株式会社 | 新型的多层聚合物涂层交联海藻酸凝胶纤维 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8505882D0 (en) | 1985-03-07 | 1985-04-11 | Central Blood Lab Authority | Purification of blood coagulation factor viii |
US5510254A (en) | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
US5863531A (en) | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5759830A (en) | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
US6379710B1 (en) | 1996-12-10 | 2002-04-30 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
WO1999013077A2 (en) | 1997-09-10 | 1999-03-18 | President And Fellows Of Harvard College | Inducible methods for repressing gene function |
EP1189629B1 (en) | 1999-02-10 | 2010-09-29 | Curis, Inc. | Peptide yy (pyy) for treating glucose metabolic disorders |
US20050249816A1 (en) | 1999-12-29 | 2005-11-10 | Wake Forest University Health Services | Tissue engineered liver constructs |
US7282366B2 (en) | 2000-04-27 | 2007-10-16 | Geron Corporation | Hepatocytes for therapy and drug screening made from embryonic stem cells |
US6716622B2 (en) | 2000-07-18 | 2004-04-06 | Uab Research Foundation | Tissue-specific self-inactivating gene therapy vector |
US20030027335A1 (en) | 2000-09-07 | 2003-02-06 | Ruley H. Earl | Genome engineering by cell-permeable DNA site-specific recombinases |
EP1409638A4 (en) | 2000-11-07 | 2004-05-19 | Pioneer Hi Bred Int | CELL CYCLE NUCLEIC ACIDS, POLYPEPTIDES AND THEIR USE |
WO2003076564A2 (en) | 2001-05-16 | 2003-09-18 | The General Hospital Corporation | Tissue-engineered organs |
JP2003033179A (ja) | 2001-07-05 | 2003-02-04 | Asahi Kasei Corp | 可逆的遺伝子導入ベクター |
WO2003080649A2 (en) | 2002-03-20 | 2003-10-02 | Regents Of The University Of Minnesota | Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
WO2004078939A2 (en) | 2003-03-03 | 2004-09-16 | University Of Massachusetts | REGULATION OF Mdm2 FUNCTION |
US20050130919A1 (en) | 2003-07-18 | 2005-06-16 | University Of Massachusetts | Regulatable promoters for synthesis of small hairpin RNA |
EP1704227B1 (en) | 2003-10-10 | 2010-01-27 | Multicell Technologies, Inc. | Immortalized hepatocytes |
US6852505B1 (en) | 2003-10-15 | 2005-02-08 | Chau-Ting Yeh | Hepatitis |
RU2006117304A (ru) | 2003-10-20 | 2007-12-10 | Нсджин А/С (Dk) | Генная терапия болезни паркинсона iv vivo |
JP4769796B2 (ja) | 2004-04-30 | 2011-09-07 | ポエティック ジェネティックス エルエルシー | ゲノム操作のためのハイブリッド型リコンビナーゼ |
WO2005112620A2 (en) | 2004-05-18 | 2005-12-01 | Massachusetts Institute Of Technology | A cre-lox based method for conditional rna interference |
US8435787B2 (en) | 2005-05-10 | 2013-05-07 | Rutgers, The State University Of New Jersey | Alginate polyelectrolyte encapsulation of embryonic stem cells |
US7579318B2 (en) | 2005-12-06 | 2009-08-25 | Centre De La Recherche De La Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
WO2007108749A1 (en) | 2006-03-20 | 2007-09-27 | Cepep Iii Ab | Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
JP2009535035A (ja) | 2006-04-25 | 2009-10-01 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ | 肝臓再生における脂肪細胞由来成体幹細胞 |
US9375440B2 (en) | 2006-11-03 | 2016-06-28 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
AU2008271050B2 (en) | 2007-06-29 | 2014-11-06 | Sarepta Therapeutics, Inc. | Tissue specific peptide conjugates and methods |
GB2467645B (en) | 2007-07-06 | 2011-12-21 | Univ London | A method of proliferating human hepatocyte cells |
US8486699B2 (en) | 2008-05-23 | 2013-07-16 | The United States Of America As Represented By The Secretary Of Agriculture | Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines |
WO2010014949A2 (en) | 2008-07-31 | 2010-02-04 | The General Hospital Corporation | Compositions comprising hepatocyte-like cells and uses thereof |
EP2405957B1 (en) | 2009-03-13 | 2020-12-23 | Mayo Foundation For Medical Education And Research | Bioartificial liver |
US8921108B2 (en) | 2009-04-21 | 2014-12-30 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Differentiated human liver cell cultures and their use in bioartificial liver systems |
EP2248889A1 (en) | 2009-05-06 | 2010-11-10 | Sanofi-Aventis | Reversibly immortalized cells as well as methods relating hetero |
JP5745423B2 (ja) * | 2009-10-28 | 2015-07-08 | 公益財団法人ヒューマンサイエンス振興財団 | 幹細胞から肝細胞への分化誘導方法 |
JPWO2011102532A1 (ja) * | 2010-02-16 | 2013-06-17 | 国立大学法人九州大学 | 誘導肝細胞 |
WO2011130402A2 (en) * | 2010-04-13 | 2011-10-20 | Cellular Dynamics International, Inc. | Hepatocyte production by forward programming |
EP2386627A1 (en) * | 2010-05-10 | 2011-11-16 | Medizinische Hochschule Hannover | Induction of a mature hepatocyte phenotype |
CN102465115B (zh) * | 2010-11-04 | 2014-03-05 | 中国科学院上海生命科学研究院 | 一种新的制备肝实质细胞的方法 |
TWI571513B (zh) | 2011-09-28 | 2017-02-21 | 幹細胞生物科技股份有限公司 | 體幹細胞及其製備方法 |
PT2800811T (pt) | 2012-05-25 | 2017-08-17 | Univ California | Métodos e composições para modificação de adn alvo dirigida por arn e para modulação dirigida por arn de transcrição |
JP5970245B2 (ja) | 2012-06-06 | 2016-08-17 | 公益財団法人ヒューマンサイエンス振興財団 | 幹細胞から肝細胞への分化誘導方法 |
CN104781393A (zh) * | 2012-09-07 | 2015-07-15 | 弗·哈夫曼-拉罗切有限公司 | 用于生产诱导肝细胞的方法和组合物 |
-
2013
- 2013-02-08 CN CN201310050796.7A patent/CN103981147B/zh active Active
-
2014
- 2014-02-08 WO PCT/CN2014/071898 patent/WO2014121758A1/en active Application Filing
- 2014-02-08 JP JP2015556390A patent/JP6426627B2/ja active Active
- 2014-02-08 US US14/422,307 patent/US9623048B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP6426627B2 (ja) | 2018-11-21 |
JP2016508369A (ja) | 2016-03-22 |
WO2014121758A1 (en) | 2014-08-14 |
US20150190427A1 (en) | 2015-07-09 |
US9623048B2 (en) | 2017-04-18 |
CN103981147A (zh) | 2014-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103981147B (zh) | 一种新的制备肝实质细胞的方法 | |
Daviaud et al. | Vascularization and engraftment of transplanted human cerebral organoids in mouse cortex | |
US20200333326A1 (en) | Human trophoblast stem cells and uses thereof | |
Kang et al. | Three-dimensional bioprinting of hepatic structures with directly converted hepatocyte-like cells | |
Jiang et al. | Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. | |
Zhou et al. | Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina | |
Sun et al. | Retinal stem/progenitor properties of iris pigment epithelial cells | |
JP7027026B2 (ja) | 眼疾患を処置するためのabcb5(+)幹細胞 | |
CN102465115B (zh) | 一种新的制备肝实质细胞的方法 | |
CN102985556B (zh) | 分离高纯度细胞群体的生理学方法 | |
CN105296418A (zh) | 一种长期体外培养和扩增肝细胞的方法及其应用 | |
CN107532144A (zh) | 层粘连蛋白用于使多能细胞分化成肝细胞谱系细胞的用途 | |
Sandrock et al. | Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders | |
WO2008066199A1 (fr) | Procédé d'induction de la différenciation de cellules souches embryonnaires en cellules sécrétrices d'insuline, cellules sécrétrices d'insuline induites par le procédé et leur utilisation | |
CN109844093A (zh) | 通过降低t细胞区室中的自身反应性来治疗免疫病症相关疾病的方法 | |
Zhang et al. | Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China | |
Liu et al. | Enhancement of long-term proliferative capacity of rabbit corneal epithelial cells by embryonic stem cell conditioned medium | |
CN109152799A (zh) | 胰腺干细胞及其用途 | |
WO2016093362A1 (ja) | 人工組織及びその製造方法 | |
Kanzaki et al. | KCNJ13 gene deletion impairs cell alignment and phagocytosis in retinal pigment epithelium derived from human-induced pluripotent stem cells | |
KR20060065712A (ko) | 간엽계 줄기세포의 간세포로의 분화 방법 및 인공 인간간장 세포 | |
Jiang et al. | Differentiation of E14 mouse embryonic stem cells into thyrocytes in vitro | |
US20230392124A1 (en) | Methods and compositions for improving sc-beta cells or enhancing their utility | |
Moshrefi et al. | Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat | |
CN111849859B (zh) | 一种经基因编辑的功能性肝实质细胞的制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140813 Assignee: Shanghai micro Zhuo Biological Technology Co., Ltd. Assignor: Shanghai Institute of life Sciences, Chinese Academy of Sciences Contract record no.: 2018990000187 Denomination of invention: Novel hepatocyte preparation method Granted publication date: 20171110 License type: Exclusive License Record date: 20180723 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200708 Address after: 200031 building 35, No. 320, Yueyang Road, Xuhui District, Shanghai Patentee after: Center for excellence and innovation of molecular cell science, Chinese Academy of Sciences Address before: 200031 No. 320, Yueyang Road, Shanghai, Xuhui District Patentee before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right |